3GV by Rx Propellant gains ‘IFC-EDGE Advanced’ sustainability certification
Achieving the certification requires a building to reach at least 40 per cent in energy saving signifying that a building is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
71 per cent rise YoY during Q1 2024 in Biopharmaceutical M&A deals: GlobalData
GlobalData’s recent The State of the Biopharmaceutical Industry 2024 report reveals that the surveyed healthcare industry…
Pfizer, AstraZeneca to invest nearly $1 bn in France
Pfizer would invest $538.5 million in France to build up its research and development work in the country, while AstraZeneca…
Deal activity in pharma industry in April 2024
Deal value declined by 45.4 per cent in April 2024, compared to April 2023: GlobalData
Atomgrid secures seed funding led by Merak Ventures
The Specialty Chemical Manufacturing platform aims to empower Indian chemical manufacturers to establish a global footprint
Cell and gene manufacturers benefit from surge in FDA drug approvals: GlobalData
As per the report, 2023 marked a significant upsurge in FDA approvals
Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn
API Holdings secured the biggest deal ($216 million), followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2…
Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
It is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
Chinese companies lead ADC development pipeline: GlobalData
A significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market.
Lupin launches biosimilar Etanercept in Canada
Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile idiopathic arthritis, active and…
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension
Maiva Pharma raises Rs 1,000 cr from Morgan Stanley, India Life Sciences Fund
The proceeds will be used to set up a new manufacturing facility near Hosur with capabilities in sterile dosage forms
GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData
According to GlobalData, there are over 50 clinical trials for type 2 diabetes or obesity treatment involving GLP-1R agonists
IIT Bombay announces launch of 10X GMP facility
The facility will expedite the translation of academic research into innovative medical products, bridging the gap between…
Sanofi’s diabetes drug Soliqua launched in India
A once-daily solution that breaks through the complexity of living with type 2 diabetes
Granules India gets ANDA approval for Colchicine capsules
Colchicine Capsules are indicated for prophylaxis of gout flares in adults
Glenmark gets ANDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the US by Glenmark Therapeutics, US
Enhertu shows positive results in DESTINY-Breast06 Phase III trial
Demonstrates statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low…
Lupin Digital Health’s Lyfe Platform gets Class C Medical Device License from CDSCO
First chronic condition management platform to be recognized as a Class C 'Software as a Medical Device'
AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData
Most of Lynparza’s sales come from ovarian and HER2-negative breast cancer treatment